Well Lead Medical Co (SHSE:603309) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603309 Well Lead Medical Co Ltd SHSE:603309
75 GF Score
Price ¥11.06
GF Value ¥14.79
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Well Lead Medical Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Well Lead Medical Co  (SHSE:603309) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Well Lead Medical Co Cyclically Adjusted PS Ratio Related Terms


Well Lead Medical Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Well Lead Medical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Well Lead Medical Co Cyclically Adjusted PS Ratio Chart

Well Lead Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.57 6.28 4.13 3.20 3.32

Well Lead Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.39 3.29 3.53 2.61

SHSE:603309 vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Well Lead Medical Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Well Lead Medical Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603309
75GF Score
Well Lead Medical Co Ltd SHSE:603309
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Well Lead Medical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Well Lead Medical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Well Lead Medical Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.411/116.0564*116.0564
=1.411

Current CPI (Jun. 2026) = 116.0564.

Well Lead Medical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.527 102.400 0.597
201612 0.579 102.600 0.655
201703 0.442 103.200 0.497
201706 0.655 103.100 0.737
201709 0.608 104.100 0.678
201712 0.688 104.500 0.764
201803 0.496 105.300 0.547
201806 0.709 104.900 0.784
201809 0.696 106.600 0.758
201812 0.932 106.500 1.016
201903 0.742 107.700 0.800
201906 1.003 107.700 1.081
201909 0.989 109.800 1.045
201912 1.074 111.200 1.121
202003 0.593 112.300 0.613
202006 1.500 110.400 1.577
202009 1.127 111.700 1.171
202012 1.096 111.500 1.141
202103 0.846 112.662 0.871
202106 0.974 111.769 1.011
202109 1.123 112.215 1.161
202112 1.348 113.108 1.383
202203 1.028 114.335 1.043
202206 1.137 114.558 1.152
202209 1.292 115.339 1.300
202212 1.226 115.116 1.236
202303 1.233 115.116 1.243
202306 1.003 114.558 1.016
202309 1.123 115.339 1.130
202312 1.411 114.781 1.427
202403 1.041 115.227 1.048
202406 1.252 114.781 1.266
202409 1.319 115.785 1.322
202412 1.538 114.893 1.554
202503 1.193 115.116 1.203
202506 1.360 114.907 1.374
202509 1.510 115.471 1.518
202512 1.508 115.832 1.511
202603 1.223 116.303 1.220
202606 1.411 116.056 1.411

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?

Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued. The current stock price of ¥11.06 is trading 25.2% below its estimated GF Value™ of ¥14.79. GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603309:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥14.79 vs. price of ¥11.06 (25.2% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Well Lead Medical Co Business Description

Address No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
75GF Score

Get the complete analysis for SHSE:603309

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.06
Price
¥14.79
GF Value